Post-menopausal Sertoli-Leydig cell tumour: a report of two cases

Authors

  • Ancy T. Jacob Department of Obstetrics and Gynaecology, Travancore Medical College, Kollam, Kerala, India
  • Jumanath A. K. Department of Obstetrics and Gynaecology, Travancore Medical College, Kollam, Kerala, India
  • Praseeda I. Department of Pathology, Travancore Medical College, Kollam, Kerala, India
  • Merin Thomas Department of Pathology, Travancore Medical College, Kollam, Kerala, India
  • Tilka Mathew Department of Pathology, Travancore Medical College, Kollam, Kerala, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20241462

Keywords:

Hyperandrogenism, Sertoli-Leydig cell tumor, Postmenopause

Abstract

Ovarian Sertoli-Leydig cell tumors (SLCTs) represent less than 0.2 percent of all ovarian cancers and are an uncommon type of sex cord–stromal malignancy. Since these tumors are discovered in young women at an early stage, the management challenge is in striking the correct balance between a treatment that is effective enough to stop recurrences but yet permits fertility preservation. We present 2 case report of patients, one presented with hirsuitism and on evaluation found to have elevated levels of serum total testosterone and suspicion of SLCTs in magnetic resonance imaging (MRI) pelvis. Total laparoscopic hysterectomy (TLH) was done with bilateral salpingo-oophorectomy (BSO) and histopathology report came as ovarian Leydig cell tumour. Second case with postmenopausal bleeding and on evaluation MRI report showed right ovarian solid tumour-fibroma/fibrothecoma. Tumour markers were normal. TLH was done with BSO, histopathology report came as ovarian SLCT.

References

Khalloufi C, Joudar I, Kanas A, Benhessou M, Ennachit M, El Kerroumi M. Ovarian Sertoli-Leydig tumor: A tricky tumor case report. Int J Surg Case Rep. 2023;105:108043.

Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, et al. A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gynecol Oncol. 2012;127:384-9.

Akman L, Ertas IE, Gokcu M, Terek MC, Sanci M, Sanli UA, et al. Ovarian Sertoli-Leydig cell tumors: a multicenter long-term clinicopathological analysis of 27 patients. J Cancer Res Ther. 2016;12:290-4.

Young RH, Scully RE. Ovarian Sertoli‐Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol. 1985;9(8):543‐69.

Caringella A, Loizzi V, Resta L, Ferreri R, Loverro G. A case of Sertoli‐Leydig cell tumor in a postmenopausal woman. Int J Gynecol Cancer. 2006;16(1):435‐8.

Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Int J Gynecol Pathol. 1999;18(3):288.

Chen J, Liu Y, Zhang Y, Wang Y, Chen X, Wang Z. Imaging, clinical, and pathologic findings of Sertoli‐leydig cell tumors. Sci Prog. 2021;104(2):368504211009668.

Sigismondi C, Gadducci A, Lorusso D, Candiani M, Breda E, Raspagliesi F, et al. Ovarian Sertoli‐Leydig cell tumors. A retrospective MITO study. Gynecol Oncol. 2012;125(3):673‐6.

Al‐Agha OM, Tahmasebi FC, Nicastri AD. A 67‐year‐old woman with abdominal distention, vaginal bleeding, and elevated CA 125 level. Pure Sertoli cell tumor of the ovary with differentiation varying from well‐differentiated tubules, to intermediate foci, to sarcomatoid spindle cell areas. Arch Pathol Lab Med. 2006;130(5):e70‐3.

Hanby AM, Walker C, Tavassoli FA, Devilee P. Pathology and genetics: Tumours of the breast and female genital organs. WHO classification of tumours series – volume IV. Lyon, France: IARC press. Breast Cancer Res. 2004;6(3):250.

Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG. Ovarian sex cord‐stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol. 2003;16(6):584‐907.

Downloads

Published

2024-05-29

Issue

Section

Case Reports